About Tenax Therapeutics
Tenax Therapeutics is a company based in Morrisville (United States) founded in 1967. The company has 6 employees as of December 31, 2024. Tenax Therapeutics offers products and services including TNX-201 and TNX-103. Tenax Therapeutics operates in a competitive market with competitors including Actelion, AskBio, Juvenescence, Inotrem and Aerovate Therapeutics, among others.
- Headquarter Morrisville, United States
- Employees 6 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tenax Therapeutics, Inc.
-
Annual Revenue
Not available
-
Net Profit
-$17.6 M (USD)-128.28as on Dec 31, 2024
-
EBITDA
-$19.49 M (USD)-136.97as on Dec 31, 2024
-
Latest Funding Round
$25 M (USD), Post-IPO
Mar 05, 2025
-
Investors
RTW Investments
& 1 more
-
Employee Count
6
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Tenax Therapeutics
Tenax Therapeutics is a publicly listed company on the NASDAQ with ticker symbol TENX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Tenax Therapeutics
Tenax Therapeutics offers a comprehensive portfolio of products and services, including TNX-201 and TNX-103.
Oral enteric coated imatinib for pulmonary hypertension treatment.
Oral levosimendan for cardiopulmonary condition therapies.
People of Tenax Therapeutics
Unlock access to complete
Unlock access to complete
Leadership Team
8 people
Scientific Team
7 people
Finance and Accounting
2 people
Operations Team
1 people
Unlock access to complete
Funding Insights of Tenax Therapeutics
Investors in Tenax Therapeutics
Tenax Therapeutics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include RTW Investments and Military Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm investing in the US
|
Locked | Locked | Locked | |
|
Administers health care and support for military personnel and operations.
|
Locked | Locked | Locked |
Investor details for Tenax Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tenax Therapeutics
Investment portfolio details for Tenax Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tenax Therapeutics
Detailed financials for Tenax Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tenax Therapeutics Comparisons
Peer comparison for Tenax Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tenax Therapeutics
Tenax Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Actelion, AskBio, Juvenescence, Inotrem and Aerovate Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Innovative treatments for orphan diseases are discovered, developed, and commercialized.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Provider of proprietary ketone ester-based therapeutic drink for age-related disorders and metabolic health
|
|
| Locked | Locked | Locked |
Developer of peptide immunotherapies for treating septic shock and acute myocardial infarction
|
|
| Locked | Locked | Locked |
Therapeutic solutions for pulmonary arterial hypertension are developed.
|
|
| Locked | Locked | Locked |
Small molecule drugs that target deubiquitylating enzymes involved in the DNA damage response
|
Detailed competitors of Tenax Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tenax Therapeutics
Complete news archive for Tenax Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tenax Therapeutics
Tenax Therapeutics was founded in 1967 and raised its 1st funding round 42 years after it was founded.
Tenax Therapeutics is headquartered in Morrisville, United States.
As of Dec 31, 2024, the latest employee count at Tenax Therapeutics is 6.
Developer of therapeutics to address cardiovascular and pulmonary diseases. The companys pipeline include levosimendan is calcium sensitizer that is approved ex-US for acute decompensated heart failure in cardiac surgery patients and Oxycyte is a PFC-based oil in water emulsion that is given intravenously to patients in order to facilitate oxygen transportation from the lungs.
Tenax Therapeutics's top competitors include Juvenescence, AskBio and Mission Therapeutics.
Tenax Therapeutics offers TNX-201 and TNX-103.
Yes, Tenax Therapeutics is publicly traded on NASDAQ under the ticker symbol TENX.
Tenax Therapeutics has 2 investors. Key investors include RTW Investments, and Military Health.
The ticker symbol of Tenax Therapeutics is TENX on NASDAQ.